US Patent Issued to SHANGHAI MEDICILON, MEDICILON PRECLINICAL RESEARCH (SHANGHAI) on Sept. 2 for "Substituted pyrrolo[3,4-cpyrazoles for treating gastric acid-related diseases" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,404,276, issued on Sept. 2, was assigned to SHANGHAI MEDICILON INC. (Shanghai) and MEDICILON PRECLINICAL RESEARCH (SHANGHAI) LLC (Shanghai).

"Substituted pyrrolo[3,4-cpyrazoles for treating gastric acid-related diseases" was invented by Feng Ren (Shanghai), Xianlian Wang (Shanghai), Yongmei Xu (Shanghai), Chunlin Chen (Shanghai) and Jinna Cai (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A class of substituted pyrrolo[3,4-c]pyrazoles for treating gastric acid-related diseases is described as represented by the following formula (I):"

The patent was filed on Aug. 26, 2019, under Application No. 17/630,122.

*For further information, including...